TH Theratechnologies Inc.

Theratechnologies to Announce Second Quarter 2025 Financial Results

Theratechnologies to Announce Second Quarter 2025 Financial Results

MONTREAL, July 03, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, today announced the Company will report financial results for its second quarter 2025 ended May 31 on Wednesday, July 9, 2025.

Given the announcement of July 2, 2025, concerning the , a conference call will not be held.

About Theratechnologies

Theratechnologies (TSX: TH) (NASDAQ: THTX) is a specialty biopharmaceutical company focused on the commercialization of innovative therapies that have the potential to redefine standards of care. Further information about Theratechnologies is available on the Company's website at , on SEDAR+ at  and on EDGAR at . Follow Theratechnologies on  and . 

Contacts:

Investor inquiries:

Philippe Dubuc

Senior Vice President and Chief Financial Officer



1-438-315-6608

Media inquiries:

Julie Schneiderman

Senior Director, Communications & Corporate Affairs



1-514-336-7800



EN
03/07/2025

Underlying

THTheratechnologies Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Theratechnologies Inc.

 PRESS RELEASE
Free
TH Theratechnologi...

Theratechnologies to Announce Second Quarter 2025 Financial Results

Theratechnologies to Announce Second Quarter 2025 Financial Results MONTREAL, July 03, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, today announced the Company will report financial results for its second quarter 2025 ended May 31 on Wednesday, July 9, 2025. Given the announcement of July 2, 2025, concerning the , a conference call will not be held. About Theratechnologies Theratechnologies (TSX: TH) (NASDAQ: THTX) is a specialty biopharmaceutical company focused on the com...

12h / 16m 1 EN
 PRESS RELEASE
Free
TH Theratechnologi...

Theratechnologies annoncera ses résultats financiers du deuxième trime...

Theratechnologies annoncera ses résultats financiers du deuxième trimestre de l’exercice financier de 2025 MONTRÉAL, 03 juill. 2025 (GLOBE NEWSWIRE) -- Theratechnologies inc. (« Theratechnologies » ou la « Société ») (TSX : TH) (NASDAQ : THTX), une société biopharmaceutique au stade commercial, annonce aujourd’hui que la Société dévoilera ses résultats financiers pour le deuxième trimestre de l’exercice financier de 2025, clos le 31 mai 2025, le mercredi 9 juillet 2025. Compte tenu de l'annonce du 2 juillet 2025, concernant , aucune conférence téléphonique ne sera tenue. À propos de The...

12h / 16m 1 EN
 PRESS RELEASE
Free
TH Theratechnologi...

Theratechnologies enters into Definitive Agreement to be Acquired by C...

Theratechnologies enters into Definitive Agreement to be Acquired by CB Biotechnology, an Affiliate of Future Pak Offer of US$3.01 in cash plus one contingent value right for potential additional aggregate payments of up to US$1.19 per shareUpfront and total potential cash consideration represent respectively a 126% and 216% premium to Nasdaq closing price on date prior to announcement of Future Pak’s initial non-binding proposalTransaction with Future Pak represents culmination of sale process whereby Theratechnologies solicited interest from a number of potential counterpartiesBoard unani...

July 3, 2025 1 EN
 PRESS RELEASE
Free
TH Theratechnologi...

Theratechnologies conclut un accord définitif en vue de son acquisitio...

Theratechnologies conclut un accord définitif en vue de son acquisition par CB Biotechnology, un membre du même groupe que Future Pak Une offre de 3,01 $ US en espèces plus un droit conditionnel à la valeur représentant des paiements supplémentaires totaux potentiels pouvant atteindre 1,19 $ US par actionLa contrepartie initiale et la contrepartie totale en espèces potentielles représentent respectivement une prime de 126 % et de 216 % par rapport au cours de clôture au Nasdaq à la date précédant l’annonce de la proposition initiale non contraignante de Future PakL’opération avec Future Pak...

July 3, 2025 1 EN
 PRESS RELEASE
Free
TH Theratechnologi...

Theratechnologies Reports on its Annual Meeting of Shareholders

Theratechnologies Reports on its Annual Meeting of Shareholders MONTREAL, May 29, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, reported the voting results from its annual meeting of shareholders held today in a virtual-only setting. Shareholders proceeded to elect the below candidates to the Company’s Board of Directors for a one-year term, appointed KPMG LLP as the Company’s auditors for the current fiscal year and approved the adoption of an omnibus long-term incentive plan...

May 29, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch